0 items - $0.00

Your shopping cart is empty

Why not add some items in our Shop

70-gene signature impacts treatment decisions in breast CA

in Blog
Comments are off for this post.



(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a study published online Oct. 26 in JAMA Oncology.



Source link

Share this article

Comments are closed.